Glucoset
Develops continuous blood glucose monitoring equipment for intensive care units
Highlights
- New on EvolcAdded 2026-10-28
About Glucoset
GlucoSet develops a continuous blood glucose monitoring system for intensive care. Its sensor accesses blood through an existing arterial catheter and has been tested in patients.
The system is intended for use by intensive care units and can be set up by nurses. It remains in development.
Founded in 2011, GlucoSet is headquartered in Oslo. It has received support from the European Union’s Horizon Europe programme and the Norwegian Research Council, and its investors include the EIC Fund.
Product: A continuous blood glucose monitoring system with a sensor that accesses blood through an existing arterial catheter.
Jobs at Glucoset
Leadership
- Simon Schwaighofer · CEOSource: company website
- Lukas Scherer · CTOSource: company website
More health & medtech companies
Grønn Jobb
Occupational health services and HMS, HR and training software for small and mid-sized Norwegian companiesNew on EvolcHelsedesign
Workplace health, safety and compliance services for Norwegian businesses, including hospitality and food-service firmsYoung companyNew on EvolcHelsekontor Forvaltning
Practice management and administration services for general practitioner clinics in NorwayYoung companyNew on EvolcHelserespons
Secure patient communication and follow-up solutions for healthcare providers in NorwayNew on EvolcHelsesenteret Instebø
Medical care, physiotherapy and health testing for patients in BergenYoung companyNew on EvolcHepro
Assistive aids and care technology for children and adults, plus the Hepro Response platform for Norwegian municipalitiesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Google Universal Analytics
- JOIN
- Squarespace